NYSCF Innovator Studies 3D Genome Architecture During Stem Cell Reprogramming
The 3D structure of a cell’s genetic code, or genome, helps guide genetic expression. Though it is known that this structure is rearranged in somatic cells...
155 Results
Clear Filters
New Type of Stem Cells that Accelerate Discovery
Normal human cells contain two copies of each gene – one inherited from a mother, and one from a father. An international collaboration of scientists including...
Stem Cell Treatments
NYSCF does not treat patients with stem cell therapies. Please visit www.clinicaltrials.gov for a complete listing of clinical trials being conducted worldwide, or consult your physician. Stem cell research...
Raising the bar on quality cells
NYSCF wants to transform stem cell treatments from dreams to reality. In order to move stem cell-based cures from the theoretical and into clinics, scientists must...
The Wall Street Journal Profiles NYSCF CEO and Co-Founder Susan L. Solomon
The Wall Street Journal profiled Susan L. Solomon, NYSCF CEO and Co-Founder. Part of the “Weekend Confidential” series, previously headlining Robert A.M. Stern, Tom Colicchio, and...
The New York Stem Cell Foundation Applauds the National Academies of Sciences, Engineering, and Medicine’s Report on Mitochondrial Replacement Techniques
The New York Stem Cell Foundation (NYSCF) applauds the National Academies of Sciences, Engineering, and Medicine’s Institute of Medicine (IOM) report released on February 3rd, 2016...
NYSCF – Druckenmiller Fellow Discovery May Help Modulate Immune System
NYSCF – Druckenmiller Fellow Larry Luchsinger, PhD, studies the energy producing centers of the cell, mitochondria, to better understand the cells that produce blood cells, hematopoietic...
NYSCF – Robertson Investigators Study and Quantify Pluripotency
NYSCF – Robertson Investigator Dr. Alexander Meissner, Broad Institute of MIT and Harvard, along with NYSCF – Robertson Investigator Dr. Gabsang Lee, John Hopkins University, explored...
NYSCF – Robertson Investigator Shows Reprogrammed Neurons ‘Rewire’ Communication Networks
NYSCF – Robertson Neuroscience Investigator Dr. Paola Arlotta, Harvard Stem Cell Institute and the Broad Institute of Harvard and MIT, showed that neuronal networks of communication...
Franziska Michor receives NYSCF – Robertson Stem Cell Prize
At The 2015 NYSCF Conference: Tenth Annual Translational Stem Cell Research Conference, NYSCF announced Franziska Michor. PhD, as the 2015 recipient of the Robertson Stem Cell...
NYSCF 10th Annual Conference: Two Nobel Laureates to Chair and Participate on Panels
At the 10th Annual NYSCF Conference on Translational Stem Cell Research NYSCF will bring together world leaders in biotechnology, regenerative medicine, precision medicine, and pharmaceuticals to...
NYSCF Speaks at NIH Workshop on Cell Culture Reproducibility
The National Institute of Health (NIH) invited Susan Solomon to chair and moderate a panel at September’s NIH Workshop on Reproducibility in Cell Culture Studies. The...
NYSCF and Q-State Biosciences collaborate to create patient-specific stem cells from blood
NYSCF announces a new partnership with Q-State Biosciences (Q-State) to generate high quality stem cells from patient blood cells. The collaboration will mark the first time...
NYSCF’s Robotic Technology on The Stem Cell Podcast with Dr. Scott Noggle
NYSCF Vice President of Stem Cell Research, Dr. Scott Noggle leads The Stem Cell Podcast through a behind-the-scenes view of NYSCF’s one-of-a-kind robotic technology that creates...
NYSCF – Robertson Investigator Works to Understand Stem Cell Pluripotentcy
NYSCF – Robertson Stem Cell Investigator Dr. Alex Meissner, Harvard University, published his latest work studying the development and interaction of binding factors in mouse stem...
The NYSCF Global Stem Cell Array™ Brings Precision Medicine One Step Closer to the Clinic
NYSCF designed and has built a revolutionary, high-throughput robotic platform that automates and standardizes the process of transforming patient samples into stem cells. This one-of-a-kind system...
NYSCF – Robertson Investigator Shows Stem Cells Can Serve as Niches for Progeny Cells
NYSCF – Robertson Stem Cell Investigator Dr. Jayaraj Rajagopal, Massachusetts General Hospital, discovered that parent stem cells can serve as niches, or cell maintenance and regulatory...
NYSCF – Robertson Investigator Works to Understand Stem Cell Transdifferentiation
NYSCF – Robertson Stem Cell Investigator Dr. Jacob Hanna, Weizmann Institute of Science, tested an alternate method of stem cell transdifferentiation – the process of a...
NYSCF Innovators Find Clues to Stem Cell Life and Death
NYSCF – Robertson Stem Cell Investigator Dr. Valentina Greco and NYSCF – Druckenmiller Fellow Dr. Panteleimon Rompolas and their team from Yale University discovered clues to...
NYSCF – Robertson Investigator Identifies iPS Cell Reprogramming Regulators
NYSCF – Robertson Stem Cell Investigator and 2014 NYSCF – Robertson Stem Cell Prize Winner Dr. Marius Wernig, Stanford University School of Medicine, discovered key cell...
NYSCF – Robertson Investigator Works to Understand Cell Differentiation
NYSCF – Robertson Stem Cell Investigator Dr. Alex Meissner, Harvard University, published his latest work on the role of transcription factors in stem cell differentiation in...
NYSCF – Robertson Investigator Studies Airway Regeneration
NYSCF – Robertson Stem Cell Investigator Dr. Jayaraj Rajagopal, Massachusetts General Hospital, published his latest research on stem cell response in injury repair in Cell Stem...
NYSCF Presents Global Stem Cell Array at NIH Workshop
Dr. Stephen Chang, NYSCF Vice President for Research and Development, presented the NYSCF Global Stem Cell Array technology at the National Institutes of Health Fifth AIMBE Workshop...
NYSCF CEO Pens Editorial on Mitochondrial Replacement Therapy
NYSCF CEO Susan L. Solomon penned an editorial in Roll Call commending the approval of mitochondrial replacement therapy, or MRT, by the UK Parliament House of Commons...
NYSCF Urges Parliament to Pass Regulations on Mitochondrial Replacement Therapy
On Tuesday, February 3rd, the UK Parliament will debate whether to approve the use of mitochondrial replacement therapy or MRT in the UK. This therapy, similar...